Glutaraldehyde fixation of venous valve tissue: A benchmark for alternative fixation methods.

bioprosthesis chronic venous disease glutaraldehyde tissue fixation venous valve

Journal

Phlebology
ISSN: 1758-1125
Titre abrégé: Phlebology
Pays: England
ID NLM: 9012921

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 8 3 2022
medline: 6 5 2022
entrez: 7 3 2022
Statut: ppublish

Résumé

Bioprosthetic venous valves have yet to achieve long-term patency due to issues with calcification following implantation that is influenced by current xenograft fixation methods, most notably glutaraldehyde. The goal of this study was to investigate the effects of glutaraldehyde fixation on the functional properties of venous tissue to establish a benchmark for the evaluation of alternative fixation methods. The degree of crosslinking was evaluated by determining shrink temperature and the stability of tissue with pronase and collagenase digestion. Glutaraldehyde fixation of venous tissue was confirmed by a significant difference in the shrink temperature between fresh and glutaraldehyde treated samples. Significant differences in the amount of tissue remaining following digestion were observed for venous versus cardiac tissue. This study demonstrates the importance of tissue-specific evaluation in the development of alternative xenograft fixation methods to improve outcomes with bioprosthetic venous valves.

Identifiants

pubmed: 35249404
doi: 10.1177/02683555221077669
doi:

Substances chimiques

Glutaral T3C89M417N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-302

Auteurs

Megan Laughlin (M)

Department of Biomedical Engineering, 3341University of Arkansas Fayetteville, Fayetteville, AR, USA.

Makenzie Kapales (M)

Department of Biomedical Engineering, 3341University of Arkansas Fayetteville, Fayetteville, AR, USA.

Keshari Thakali (K)

Department of Pediatrics, 12215University of Arkansas for Medical Sciences, Little Rock, AR, USA.
57731Arkansas Children's Nutrition Center, Little Rock, AR, USA.

Marc Girardot (M)

VeinTek, LLC, Atlanta, GA, USA.

Morten Jensen (M)

Department of Biomedical Engineering, 3341University of Arkansas Fayetteville, Fayetteville, AR, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH